Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan
Authors:
Open Access
- 16 March 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (3) , e0194149
Abstract
The study aimed to describe the evolution of the seroprevalence of hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-positive patients included in two cohorts in Taiwan. We retrospectively collected the information on demographic and clinical characteristics of 4,025 and 3,856 HIV-positive Taiwanese, who were aged 18 years or older at designated hospitals around Taiwan in 2004–2007, when an outbreak of HIV infection was occurring, and 2012–2016, when the outbreak was controlled with the implementation of harm reduction program, respectively. Comparisons of HCV seropositivity were made among different age and risk groups for HIV transmission between these two cohorts. The overall HCV seroprevalence of the 2004–2007 cohort and 2012–2016 cohort was 43.4% (1,288/2,974) and 18.6% (707/3,793), respectively (PP = 0.02), respectively, and all age groups. In contrast, the corresponding figures among men who have sex with men (MSM) and heterosexuals in the two cohorts were 5.9% vs. 3.5% (P = 0.002) and 9.4% vs. 10.9% (P = 0.59), respectively. Among sexually transmitted HIV-positive patients, HCV seropositivity was significantly correlated with age (adjusted odds ratio [aOR], per 1-year increase, 1.03; 95% confidence interval [CI], 1.02–1.05) and a rapid plasma reagin (RPR) titer ≥1:8 (aOR, 1.58; 95% CI, 1.03–2.43) in a multivariate analysis including age, gender, route for HIV transmission, baseline CD4 count and plasma HIV RNA load, the presence of hepatitis B surface antigen, and an RPR titer ≥1:8. Compared with heterosexuals, the aOR for HCV seropositivity among MSM was 0.47 (95% CI, 0.31–0.72). HCV seroprevalence among HIV-positive patients in Taiwan decreased with time, probably related to the inclusion of younger adults and more non-IDUs, and remained high among IDUs. HCV seropositivity was associated with age and an RPR titer ≥1:8 among patients who acquired HIV through sexual contact.Keywords
Funding Information
- Taiwan Centers for Disease Control
This publication has 30 references indexed in Scilit:
- Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-upPLOS ONE, 2017
- Hepatitis C virus infectionEuropean Journal of Gastroenterology & Hepatology, 2017
- Emerging viral STIs among HIV-positive men who have sex with men: the era of hepatitis C virus and human papillomavirusSexually Transmitted Infections, 2016
- Effects of combination approach on harm reduction programs: the Taiwan experienceHarm Reduction Journal, 2016
- Global distribution and prevalence of hepatitis C virus genotypesHepatology, 2014
- Changes in HIV Incidence among People Who Inject Drugs in Taiwan following Introduction of a Harm Reduction Program: A Study of Two CohortsPLOS Medicine, 2014
- Recent Hepatitis C Virus Infections in HIV-Infected Patients in Taiwan: Incidence and Risk FactorsJournal of Clinical Microbiology, 2012
- Effects of education on harm-reduction programmesThe Lancet, 2012
- Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based StudyThe Kaohsiung Journal of Medical Sciences, 2010
- Seroprevalence of Chronic Hepatitis B Virus Infection Among Taiwanese Human Immunodeficiency Virus Type 1–Positive Persons in the Era of Nationwide Hepatitis B VaccinationAmerican Journal of Gastroenterology, 2009